[09 April 2013]
Products Affected - Description
Labetalol tablets, Teva
100 mg, 100 count Unit Dose (NDC 00172-4364-10) - discontinued
Trandate tablets, Prometheus
100 mg, 100 count (NDC 65483-0391-10)
200 mg, 100 count (NDC 65483-0392-10)
300 mg, 100 count (NDC 65483-0393-10)
Reason for the Shortage
- Prometheus cannot provide a reason for the shortage.
- Teva discontinued labetalol 100 mg, 100 count unit dose tablets in November 2012.
- Watson had labetalol tablets on back order due to increased demand.
Available Products
Labetalol tablets, Major
100 mg, 100 count (NDC 00904-5928-61)
200 mg, 100 count (NDC 00904-5929-61)
300 mg, 100 count (NDC 00904-5930-61)
Labetalol tablets, Sandoz
100 mg, 100 count (NDC 00185-0010-01)
100 mg, 500 count (NDC 00185-0010-05)
200 mg, 100 count (NDC 00185-0117-01)
200 mg, 500 count (NDC 00185-0117-05)
300 mg, 100 count (NDC 00185-0118-01)
300 mg, 500 count (NDC 00185-0118-05)
Labetalol tablets, Teva
100 mg, 100 count (NDC 00172-4364-60)
100 mg, 500 count (NDC 00172-4364-70)
200 mg, 100 count (NDC 00172-4365-60)
200 mg, 100 count, unit dose (NDC 00172-4365-10)
200 mg, 500 count (NDC 00172-4365-70)
300 mg, 100 count (NDC 00172-4366-60)
Labetalol tablets, UDL
100 mg, 100 count, unit dose (NDC 51079-0928-20)
200 mg, 100 count, unit dose (NDC 51079-0929-20)
Labetalol tablets, Watson
100 mg, 100 count (NDC 00591-0605-01)
100 mg, 500 count (NDC 00591-0605-05)
200 mg, 100 count (NDC 00591-0606-01)
200 mg, 500 count (NDC 00591-0606-05)
300 mg, 100 count (NDC 00591-0607-01)
Estimated Resupply Dates
- Prometheus has all Trandate tablets on a long term back order and the company cannot estimate a release date.
- All other presentations of labetalol tablets are fully available.
Related Shortages
Updated
April 9, 2013; March 5, 2013; February 7, 2013; January 25, 2013; December 14, 2012; October 26, 2012; October 3, 2012; September 7, 2012; August 30, 2012; August 7, 2012; July 26, 2012; July 5, 2012; June 22, 2012; May 15, 2012; April 11, 2012; March 22, 2012; February 28, 2012; February 15, 2012; January 30, 2012; January 9, 2012; January 3, 2012; December 15, 2011; November 30, 2011; November 9, 2011; September 30, 2011, University of Utah, Drug Information Service. Copyright 2013, Drug Information Service, University of Utah, Salt Lake City, UT.
Disclaimer
This information is provided through the support of Novation to ASHP solely as a service to its members, which shall not use this information for their further commercial use. The content was prepared by the Drug Information Center of University of Utah. Novation, ASHP, and the University of Utah make no representations or warranties, express or implied, including, but not limited to, any implied warranty of merchantability and/or fitness for a particular purpose, which respect to such information, and specifically disclaim all such warranties. Users of this information are advised that decisions regarding the use of drugs and drug therapies are complex medical decisions and that in using this information, each user must exercise his or her own independent professional judgment. Neither Novation, ASHP nor the University of Utah assumes any liability for persons administering or receiving drugs or other medical care in reliance upon this information, or otherwise in connection with this bulletin. Neither Novation, ASHP nor University of Utah endorses or recommends the use of any drug.
« Back to Drug Shortage Product Bulletins